<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30189">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02713698</url>
  </required_header>
  <id_info>
    <org_study_id>2015.221(183-DEFI/165-CES)</org_study_id>
    <nct_id>NCT02713698</nct_id>
  </id_info>
  <brief_title>Propofol Pharmacokinetics and Pharmacodynamics Modelling</brief_title>
  <official_title>Modelling Propofol Pharmacokinetics and Pharmacodynamics During an Intravenous Anaesthesia Guided by the Bispectral Index (BIS)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centro Hospitalar do Porto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centro Hospitalar do Porto</source>
  <brief_summary>
    <textblock>
      The main purpose of this research is to develop a population pharmacokinetic and
      pharmacodynamic model of Propofol when used for induction and maintenance of anaesthesia,
      using BIS as a pharmacodynamic endpoint.

      A covariate analysis will be performed in order to account for variability in
      pharmacokinetic and pharmacodynamic parameters. The influence of age and obesity on propofol
      pharmacokinetic parameters will be particularly addressed.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Compartmental pharmacokinetic-pharmacodynamic analysis (concentration-time curve), using BIS as a pharmacodynamic endpoint.</measure>
    <time_frame>up to 2 hours</time_frame>
    <description>Pharmacokinetic parameters are volume of central and peripheral compartments, intercompartmental clearance and body clearance.</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Intravenous Anesthetic Agent Overdose</condition>
  <arm_group>
    <arm_group_label>Propofol - adults not obese</arm_group_label>
    <description>Patients with 18 or more years presenting for inpatient nose and ear surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol - obese</arm_group_label>
    <description>Patients with 18 or more years presenting for inpatient bariatric surgery.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Propofol - elderly</arm_group_label>
    <description>Patients with 65 or more years presenting for urgent orthopaedic surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>Induction of general anaesthesia: propofol at 200 mL/h until loss of consciousness (LOC).
Maintenance of general anaesthesia: propofol will be altered by 5 mg/mL changes targeting the BIS values between 40 and 60.
Arterial blood samples will be obtained immediately after LOC, immediately before surgery and after every 20-30 minutes during propofol infusion. After stopping propofol infusion, arterial blood samples will be acquired every 10 minutes until recovery of consciousness. The maximum blood sample per patient will be 20 mL.</description>
    <arm_group_label>Propofol - adults not obese</arm_group_label>
    <arm_group_label>Propofol - obese</arm_group_label>
    <arm_group_label>Propofol - elderly</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Arterial blood samples will be collected in serum tubes and centrifuged at 2000 rpm for 15
      minutes in order to obtain serum. Serum will be preserved at -80ÂºC until analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Inpatient care at Centro Hospitalar do Porto
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients admitted for nose or ear surgery, bariatric surgery or urgent
             orthopaedic surgery.

        Exclusion Criteria:

          -  Severe hepatic or renal insufficiency;

          -  Significant haemodynamic instability previous to the surgery;

          -  Allergy to eggs or propofol at the time of enrolment;

          -  Predictive criteria for difficult airway management.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Araujo, MD</last_name>
      <email>amfariaaraujo@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <lastchanged_date>April 18, 2016</lastchanged_date>
  <firstreceived_date>February 23, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centro Hospitalar do Porto</investigator_affiliation>
    <investigator_full_name>Ana M Araujo</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Anaesthetics</keyword>
  <keyword>Intravenous</keyword>
  <keyword>Propofol</keyword>
  <keyword>Pharmacokinetics</keyword>
  <keyword>Pharmacodynamics</keyword>
  <keyword>Propofol pharmacokinetic-pharmacodynamic model</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
